Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations.
about
Red cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseRed cell transfusion management for patients undergoing cardiac surgery for congenital heart diseaseThe care for adults with congenital heart disease: organization and function of a grown-up congenital heart disease unit.Factors determining outcomes in grown up patients operated for congenital heart diseases.Timing of pulmonary valve replacement after tetralogy of Fallot repair.Outcomes of redo pulmonary valve replacement for bioprosthetic pulmonary valve failure in 61 patients with congenital heart disease.Nineteen Years of Adult Congenital Heart Surgery in a Single Center.Mortality Following Congenital Heart Surgery in Adults Can Be Predicted Accurately by Combining Expert-Based and Evidence-Based Pediatric Risk Scores.Cardiac surgery in adults with high-surgical complexity CHD: results of a network collaborative programme.Inhibition of factor IXa by the pegnivacogin system during cardiopulmonary bypass: a potential substitute for heparin. A study in baboons.Transcatheter interventions for multiple lesions in adults with congenital heart disease.Peri-operative care in adults with congenital heart disease: room for improvement in after care.Short-Term Costs and Hospitalization Rates in Patients With Adult Congenital Heart Disease After Pulmonic Valve Replacement.Porcine bioprosthetic valve in the pulmonary position: mid-term results in the right ventricular outflow tract reconstruction.Midterm results of surgery for adults with congenital heart disease centralized to a Swedish cardiothoracic center.Dehiscence of a pulmonary bioprosthesis with a focal dissection of the pulmonary artery in a patient with congenital pulmonic stenosis.Reoperative double ventricular outflow tract reconstruction in grown-up congenital heart disease patients with conotruncal anomalies.Risk factors associated with morbidity and mortality after pulmonary valve replacement in adult patients with previously corrected tetralogy of Fallot.
P2860
Q24200508-6CFA5C7A-34D2-4FE6-BA07-691F75E873E2Q24201453-E8EC2EB7-B872-4A11-8C03-5FC89F8055CDQ33646848-1D30C3E2-57E7-4CF7-9954-E29783231F4FQ37224530-4DD18A1A-35C1-4435-87B6-DAC860168F4EQ38036336-2672E8D2-E05A-4A38-9E15-34556A0930F8Q38740328-89120910-5CE0-4944-8025-E9BB4997E32AQ38741497-36B5635B-6800-45CB-A69A-2CEB47408E61Q39643879-1B88B522-DB8C-4722-833B-77D013465443Q40067710-400DAAA0-7DEE-4ACA-834F-EE03C727BE7AQ40962346-E36643FF-3181-479E-92B7-503E41B37B04Q42134941-AEAACAEA-BBC6-429E-B946-A8A7D0486674Q42670470-0368253A-4694-4496-9659-0DCFEABE82A1Q43512210-26B91176-97AD-4B8D-A673-CE4DDF380530Q43551056-A4E6FD04-962F-4557-ACD9-2CF675BD5718Q44853869-E9246CB3-69CD-4EF5-A74F-4C646EF40F5EQ48360200-FB419566-DF73-4A93-803E-8E428FD161B1Q52149916-4BD3375C-0802-4E4A-8B24-DABB97C9A106Q53666580-A8E3FEF2-AE47-4EC2-98D6-AD8C9E73288C
P2860
Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Morbidity and mortality risk f ...... dergoing cardiac reoperations.
@en
Morbidity and mortality risk f ...... dergoing cardiac reoperations.
@nl
type
label
Morbidity and mortality risk f ...... dergoing cardiac reoperations.
@en
Morbidity and mortality risk f ...... dergoing cardiac reoperations.
@nl
prefLabel
Morbidity and mortality risk f ...... dergoing cardiac reoperations.
@en
Morbidity and mortality risk f ...... dergoing cardiac reoperations.
@nl
P2093
P1476
Morbidity and mortality risk f ...... ndergoing cardiac reoperations
@en
P2093
Alessandro Frigiola
Alessandro Giamberti
Concetta Carlucci
Gianfranco Butera
Halkawt Nuri
Raul Abella
P304
P356
10.1016/J.ATHORACSUR.2009.05.060
P407
P577
2009-10-01T00:00:00Z